Lippman Evan

Lippman Evan is listed in filings as EVP at Teva Pharmaceutical Industries Limited. This profile follows SEC Form 4 activity through May 18, 2026, including sale activity. Recent filings connect the profile to Teva Pharmaceutical Industries Limited (TEVA). The current snapshot covers public activity from May 19, 2025 to May 18, 2026. Reported amounts are shown as $204.5K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.